To evaluate the outcomes of patients who underwent microdenervation of the spermatic cord (MDSC) for postvasectomy pain syndrome (PVPS) at our institution.
Results
A total of 27 patients with 28 scrotal units underwent MDSC for PVPS. The median (1st quartile; 3rd quartile) follow-up was 10 (2; 16.5) months. The median (range) duration of pain prior to surgery was 57 (8-468) months. Pain was bilateral in 14 (52%), left-sided in eight (30%) and right-sided in five patients (19%). Data on SCB were available for 23 patients, with a success rate of 96%. The median (range) preoperative pain NRS score was 7 (2-10). The median (range) pain score after SCB on the NRS scale was 0 (0-5). The median (range) postoperative pain score on the NRS was 0 (0-9). Overall success was achieved in 20 of 28 testicular units (71%). Patients with involvement of multiple structures in the scrotum (i.e. testis, epididymis, spermatic cord) had a success rate of 81% and were more likely to have a successful surgery (P < 0.001). Five patients had failed a prior epididymectomy and three had failed a vaso-vasostomy for PVPS; this had no correlation with the success of MDSC (P = 0.89).
Conclusion
The MDSC procedure is a reasonably successful, durable and valuable approach for PVPS, especially when pain involves multiple structures in the scrotum (testis, epididymis, spermatic cord). MDSC was equally efficacious in patients who had previously failed a procedure for PVPS. No patient had a worsening NRS score after MDSC. This is the largest study to date evaluating MDSC for the treatment of PVPS.
Introduction
Vasectomy is the most effective method of male contraception available. An estimated 500, 000 vasectomies are performed in the USA per annum, with almost 43 million men worldwide having undergone a vasectomy [1] . This procedure involves isolation and occlusion of the vas deferens. In the USA, all vasectomy techniques entail a complete transaction of the vas deferens, with or without excision of a segment of the vas deferens, followed by electrocautery fulguration of the ends of the vas deferens, placement of sutures or clips on each end and/or interposition of tissue between the two cut ends to further prevent recanalization [2] . The success rate of the procedure is estimated to be between 98% and 99% [3, 4] . The most common complications include bleeding, development of a haematoma and infection of the scrotal incision sites.
Although rare, patients may experience chronic scrotal content pain after a vasectomy. The 2012 AUA guidelines for vasectomy, which were updated in 2015, state that 1-2% of men who undergo a vasectomy will develop chronic scrotal content pain that is severe enough to interfere with their quality of life, requiring medical attention [2] .
This syndrome has been referred to by many names, including chronic orchialgia, testialgia, chronic scrotal content pain, post-vasectomy orchialgia, congestive epididymitis and chronic testicular pain. Presently, the syndrome is widely known as post-vasectomy pain syndrome (PVPS) [5] . PVPS is defined as a constant or intermittent scrotal content discomfort/pain lasting at least 3 months, with severity that interferes with daily activities and prompting the patient to seek medical treatment [6] . Multiple surgical treatment methods, including resecting the vasectomy site and/or excision of granulomas, epididymectomy, vasectomy reversal, microdenervation of the spermatic cord (MDSC) and orchiectomy, for severe cases, have been proposed to treat chronic testicular pain (Table 1 ). To the best of our knowledge, there is no article in the literature evaluating the outcomes of MDSC for PVPS. The aim of the present study was to evaluate the outcomes of patients who underwent MDSC for PVPS by a single surgeon at our institution.
Methods
We conducted an institutional review board-approved retrospective review of all patients who underwent MDSC by a single surgeon between March 2002 and October 2016 at our single institution. Complete medical records of both office and hospital charts were reviewed, including initial history and physical examination, laboratory values and operative reports.
We included men whose onset of scrotal content pain began after undergoing a vasectomy and who underwent a MDSC at our institution. The number of involved scrotal structures was based on physical examination performed by a single attending surgeon and broken down into solely the testicle, epididymis and/or spermatic cord. All patients had failed medical therapy (NSAIDS, antidepressants and/or anticonvulsants) prior to MDSC. Our pathway for management of scrotal content pain is shown in Fig. 1 . All pain scores were documented using the numerical rating scale (NRS). The NRS is a based on a scale of 0-10 and has been validated to evaluate pain in multiple settings pertaining to acute and chronic pain [32, 33] ; however, the NRS has not been validated for evaluation of scrotal content pain. Spermatic cord block (SCB) was performed on all patients, and success was defined as NRS score ≤1 for >4 h. Surgical success was defined as postoperative NRS score ≤1. A decrease in pain score based on NRS was derived from subtracting postoperative pain on the NRS from preoperative 
Spermatic Cord Block
The SCB is performed by isolating the spermatic cord at the inguinal-scrotal junction [34, 35] . A 27-gauge 3.8cm needle is then introduced into the area of the spermatic cord at the level of the pubic tubercle. We typically use 20 mL of 0.25% bupivacaine hydrochloride for the initial SCB. The patient is instructed to call the office after 24 h to report the duration and level of pain relief, if any, from the block. Should he experience ≥90% temporary relief of his pain, we offer a series of SCBs every 2 weeks for 4-5 blocks using 9 mL of 0.75% bupivacaine hydrochloride, combined with 1 mL (10 mg) of triamcinolone acetonide.
Diagnosis of PVPS Established
Identify specific pain location: testicle, vas deferens, epididymis.
Consider trial of NSAIDS, tricyclic antidepressants and/or gabapentin, scrotal support and rest. Pelvic floor physical therapy should be considered if + 360° digital rectal exam 
Microdenervation of the Spermatic Cord
We typically perform MDSC as a day surgery procedure under general anaesthesia with the aid of an operating microscope at 4-8 9 power. The patient is placed in the supine position and, after skin preparation, an oblique 3-4-cm inguinal incision is centred over the external inguinal ring. The spermatic cord is then isolated circumferentially and the ilioinguinal nerve is identified, typically running along the lateral surface of the cord. A 2-3-cm segment of the nerve is excised, and the cut ends are ligated with a 4/0 silk suture. Subsequently, the nerve is buried under the external inguinal ring to decrease the risk of neuroma formation. We use electrocautery to transect fibres of the genital branch of the genitofemoral nerve, which are reported to run along the floor of the inguinal canal. The spermatic cord is then elevated and a Penrose drain (1.6cm) is placed underneath the cord with both ends of the Penrose drain secured to the drape.
The operating microscope is brought to the field and the anterior spermatic cord fascia is incised exposing the cord contents. Ultrasonography, using a 20-MHz microvascular Doppler system (Vascular Technology, Inc., Nashua, NH, USA), is used to identify the testicular, cremasteric and deferential arteries (Fig. 2) . The arteries are secured with micro-vessel loops. All identifiable lymphatics are spared to decrease the risk of hydrocele formation. The vas deferens is divided at the level of the external ring, given that 50% of the nerves in the spermatic cord are in close proximity to the vas deferens [36] . The internal spermatic veins are subsequently divided then ligated. The cremasteric musculature and spermatic cord fascia are divided using electrocautery, given >20% of nerves are found in the cremasteric fascia [36] . No veins are intentionally preserved.
Before closure, microvascular Doppler is used to check for pulsatile flow within the preserved arteries. Rarely, topical papaverine is applied to the vessel surface to encourage vasodilation if poor flow as a result of arterial spasm is noted. The cord is then returned to its original position and 10 mL of 0.25% bupivacaine without epinephrine is injected around the wound. The incision is closed in layers.
Statistical Analysis
Data were collected and maintained in a Microsoft Excel (Microsoft, Redmond, WA, USA) spreadsheet format. Data were analysed using STATA v14.0 (StataCorp LP, College Station, TX, USA). Student's t-test was used to evaluate the relationship between the involvement of multiple scrotal structures and surgical success. The chi-squared test was also used to evaluate procedures performed prior to MDSC and surgical success. Data were reported as medians, 1st and 3rd quartiles. P values <0.05 were taken to indicate statistical significance. Data on SCB were available on 23 patients, with a success rate of 96%. The median (1st quartile; 3rd quartile) preoperative pain score on the NRS was 7 (6; 8, Table 2 ), after SCB it was 0 (0; 0), and postoperatively it was 0 (0; 3). Overall success was achieved in 20 of 28 testicular units (71%). Of 27 patients, 21 (78%) had pain involving multiple scrotal content structures. Success was obtained in 17 of the 21 (81%) of this cohort. Student's t-test was performed, reviewing patients with involvement of multiple structures in the scrotum (i.e. testis, epididymis, spermatic cord; Table 3 ), and patients who had multiple structures involved were more likely to have successful surgery (P < 0.001). Five patients (19%) and three patients (11%) out of 27 failed a prior epididymectomy and vasovasostomy for PVPS, respectively. The chi-squared test showed that procedures performed prior to MDSC had no correlation with success (P = 0.89). One patient had cellulitis at the site of incision, requiring oral antibiotics. No postoperative hydroceles or testicular atrophy were noted in this population.
Discussion
The condition PVPS is extremely frustrating to treat, for both the clinician and the patient, as there remains no widely accepted protocol for the evaluation and treatment of it.
PVPS differs from acute post-procedure pain, which typically resolves between 2 and 4 weeks [37] .
The pathophysiology for PVPS is unclear, but proposed theories with regard to the mechanism leading to pain include: (i) congestion causing back pressure as a result of the vas deferens/epididymis getting trapped between two opposing forces when ejaculation occurs; (ii) an immune response resulting in an inflammatory effect on the scrotal and spermatic cord nerve structures; and (iii) perineural fibrosis from fluid being discharged into the caudal epididymis, increasing the pressure in the epididymis and causing epidydimal fibrosis. The described mechanisms, together or individually, may ultimately result in PVPS [38] .
In our cohort, all patients who were diagnosed with PVPS underwent a thorough history and physical examination, followed by SCB in the office. A trial of NSAIDs, antidepressants, or anticonvulsants is offered to the patient if medical therapy has not been attempted ( Fig. 1 ) [39] . NSAIDs are attempted for 2-4 weeks. After failure of NSAID therapy, we proceed with a tricyclic antidepressant for at least 1 month. Although there has been no clinical trial demonstrating the efficacy of tricyclic antidepressants in PVPS, Sinclair et al. [38] found that 66.6% of patients with idiopathic testicular pain had improvement of pain using nortriptyline in a small trial of six patients after 3 months [40] .
It is our practice to only perform MDSC on patients who have a positive response to SCB. Only 23 of the 27 patients underwent SCB in our practice as the other four patients had a positive SCB performed by their referring urologist at another hospital. All four patients claimed that the SCB reduced their pain significantly, hence MDSC was offered to them.
In our cohort, 14 patients had bilateral testicular pain. We typically perform MDSC first on the more severely affected side. Of the 14 patients, 12 had total resolution of their pain after the MDSC on the more severely affected side and did not require a second procedure on the contralateral spermatic cord. We believe that this is attributable to referred pain to the contralateral scrotal structures, but the actual mechanism is not clearly understood. In the two patients who did not have resolution of the scrotal content pain, MDSC was performed on the contralateral spermatic cord for one of them. That patient had a postoperative NRS score of 0 after bilateral MDSC. The second patient was lost to follow-up.
We also compared our PVPS cohort with patients who underwent MDSC for orchialgia not related to PVPS. A total of 108 patients underwent MDSC for orchialgia not related to PVPS. Patients who underwent MDSC for PVPS had a postoperative mean pain score of 1.56 compared with a score of 2.05 in the cohort that underwent MDSC for non-PVPS causes. NRS, numerical rating scale; SCB, spermatic cord block. Other techniques used to treat PVPS include resecting the vasectomy site or sperm granuloma, laparoscopic denervation of the spermatic cord, vaso-vasostomy, epididymectomy, resection of the genitofemoral nerve and, in severe circumstances, orchiectomy through an inguinal approach. The reported success rates range from 55 to 100% (Table 1) ; however, these studies had small sample sizes, making the results difficult to duplicate in larger studies [41] . There has only been one study to date that has specifically evaluated the success rate of spermatic cord denervation for PVPS. That was a retrospective survey performed by Ahmed et al. [10] in 1997. A total of 17 patients underwent spermatic cord denervation, with a 76% success rate. This was done without the assistance of a surgical microscope. That study was confounded by both response and recall biases.
West et al. [23] reviewed 16 patients who underwent epididymectomy for pain after vasectomy (three bilateral, 13 unilateral). A total of 14 patients experienced excellent initial symptomatic benefit after epididymectomy. Ten patients were followed up for at least 3 years and nine of them had sustained improvement in their scrotal pain. The complete response rate was not listed by the author. Lee et al. [28] reviewed 22 patients who underwent epididymectomy and 16 who underwent vasectomy reversal for PVPS. The difference in the mean preoperative and postoperative visual analogue pain scale scores was 6.00 AE 1.34 (range 3-8) in the epididymectomy group and 5.50 AE 1.03 (range 4-8) in the vasectomy reversal group. Lee et al. reported a 29% complete relief of pain in the epididymectomy arm, which was 2.5-fold lower than our success rate of 71% for MDSC for PVPS [33] .
Polackwich et al. [21] identified 26 patients who underwent a vasectomy reversal and seven patients who underwent an epididymo-vasostomy for PVPS. A total of 34% of patients had complete resolution of pain and 59% of patients reported improvements in pain scores. Horovitz et al. [20] performed vasectomy reversal for 23 patients with follow-up on 14 patients. The author reported a complete success rate of 50% [20] . Our success rate of 71% for MDSC in PVPS is twofold higher than the data reported by Polackwich et al. and 1.5-fold higher than those reported by Horovitz et al.
Limitations of the present study include its retrospective nature and small sample size. Nevertheless, this study is the largest to date evaluating MDSC for PVPS. Another limitation is that all cases were performed by a single surgeon. One common theme in the literature is that many techniques often have exceptional results in the hands of individual surgeons promoting that technique. It is difficult to determine whether it is the technique itself or the relationship between a surgeon and technique that makes a difference. Perhaps the precision employed and the lack of seemingly trivial technical missteps that occur when a surgeon has significant comfort and experience with a technique results in superior outcomes. PVPS also has a rather low incidence rate, making it difficult to develop a standardized pathway and to conduct prospective randomized controlled trials.
In conclusion, PVPS remains a challenge to clinicians because of its poorly understood pathophysiology. Large multicentre, well-constructed trials are essential in order to establish level 1 evidence to facilitate a standardized algorithm to approach this condition, but given it is a rather uncommon problem, this makes a randomized controlled trial difficult to execute. Our evaluation and treatment algorithm for patients with PVPS is shown in Fig. 1 . A multidisciplinary approach including pain clinic services, a psychologist/psychiatrist, and a pelvic floor physical therapist, along with the urologist, is warranted prior to considering surgery. When non-surgical treatments fail, MDSC remains a valuable approach with reasonably high success rates and it should be considered for patients with PVPS who are refractory to medical therapy. MDSC appears to have the highest success rate in patients who experience temporary and near-complete relief after SCB, and can significantly improve the patients' quality of life and ability to return to daily activities.
